- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03431519
Percutaneous Injection Plus Short Segment Pedicle Screw Fixation for Traumatic A2 and A3 AO-type Fractures in Adults (NEOGEL)
Percutaneous Injection of Strontium Containing Hydroxyapatite Versus Polymethacrylate Plus Short Segment Pedicle Screw Fixation for Traumatic A2 and A3 AO-type Fractures in Adults
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Introduction Polymethacrylate (PMMA) is commonly used in vertebroplasty and balloon kyphoplasty, but its use has been associated with complications. This study tests three hypotheses: 1) whether strontium hydroxyapatite (Sr-HA) is equivalent to PMMA for restoring thoracolumbar vertebral body fractures, 2) if incidence of PMMA leakage is similar to that of Sr-HA leakage, and 3) whether Sr-HAis resorbed and substituted by new vertebral bone.
Materials and Methods Two age- and sex-matched groups received short percutaneous pedicle screw fixation plus PEEK implant (Kiva, VCF Treatment System, Benvenue Medical, Santa Clara, CA, USA) filled with either Sr-HA (Group A) or PMMA (Group B) after A2- and A3/AO-type thoracolumbar vertebral body fractures. Visual Analog Scale (VAS) score and imaging parameters, which included segmental kyphosis angle (SKA), vertebral body height ratios (VBHr), spinal canal encroachment (SCE), bone cement leakage, and Sr-HA resorption, were compared between the two groups.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- One single, severely (>40%) compressed A2 and A3/AO-type thoracolumbar (T10-L3) fracture
- No other serious concomitant injuries
Exclusion Criteria:
- Polytrauma
- Neurologic impairment
- Spinal deformity
- Known malignancy
- Previous fracture or surgery in the same or adjacent vertebrae
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Group A
The subjects received VP with PEEK and Sr-HA
|
Percutaneous Injection of Strontium Containing Hydroxyapatite versus Polymethacrylate plus Short Segment Pedicle Screw Fixation
Other Names:
|
Group B
The subjects received VP with PEEK and PMMA
|
Percutaneous Injection of Strontium Containing Hydroxyapatite versus Polymethacrylate plus Short Segment Pedicle Screw Fixation
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Analog Scale (VAS)
Time Frame: 33 months
|
Units on VAS scale (0-10)
|
33 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Segmental kyphosis angle (SKA)
Time Frame: 33 months
|
Angle degrees measured on Xrays
|
33 months
|
Vertebral body height ratios (VBHr)
Time Frame: 33 months
|
Percentage measured on Xrays
|
33 months
|
Spinal canal encroachment (SCE)
Time Frame: 33 months
|
Percentage measured on CT scans
|
33 months
|
Cement leakage
Time Frame: 33 months
|
Yes or no (Boolean value)
|
33 months
|
Sr-HA resorption
Time Frame: 33 months
|
Yes or no (Boolean value)
|
33 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Vasileios Syrimpeis, MD, General Hospital of Patras
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018NEOGEL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thoracic Fracture
-
St. Louis UniversityTerminatedCompression Fracture of Thoracic Vertebral Body | Thoracic Fracture | Lumbar Fracture | Compression Fracture of Lumbar Spine | Burst Fracture of Thoracic Vertebra | Burst Fracture of Lumbar VertebraUnited States
-
Assiut UniversityUnknownThoracic Epidural Analgesia, Fracture Ribs
-
Aesculap AGCompletedThoracic Fracture | Lumbar FractureGermany
-
University of California, San FranciscoTerminatedThoracic Injury | Rib Fracture | Sternal FractureUnited States
-
BG UnfallklinikCompletedThoracic Spine Fracture | Concomitant Sternal Fracture
-
Hospital de GranollersCompleted
-
Zimmer BiometRecruitingRib; FractureAustralia, Korea, Republic of
-
Zagazig UniversityRecruiting
-
Sklifosovsky Institute of Emergency CareRecruitingSpine Fusion | Spine Fracture | Thoracic Spine Fracture | Thoracolumbar Burst Fracture | Lumbar; Spine, Fracture | Fracture of Spine, Level UnspecifiedRussian Federation
-
Milton S. Hershey Medical CenterCompletedTrauma | Rib Fracture
Clinical Trials on VP
-
National Institute of Allergy and Infectious Diseases...United States Department of DefenseCompletedHIV InfectionsUganda, Kenya, Tanzania
-
Rigshospitalet, DenmarkUniversity of Copenhagen; Centre for Clinical EducationCompleted
-
National Institute of Allergy and Infectious Diseases...Centers for Disease Control and Prevention; International AIDS Vaccine Initiative and other collaboratorsWithdrawn
-
Imperial College LondonAstraZeneca; University of OxfordActive, not recruitingCovid19 | SARS-CoV-2 InfectionUnited Kingdom
-
National Institute of Allergy and Infectious Diseases...HIV Vaccine Trials NetworkCompleted
-
PYC TherapeuticsRecruitingRetinal Dystrophy | PRPF31 Mutationassociated Retinal Dystrophy | RP11United States
-
Verrica Pharmaceuticals Inc.Instat Clinical Research; HeartcoR Solutions; Myonex; Vial Health Technology, IncRecruitingCarcinoma | Skin Cancer | Basal Cell Carcinoma | Cancer of the Skin, Basal Cell | Cancer of the SkinUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedHealthy Adult Immune Responses to VaccineUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
Verrica Pharmaceuticals Inc.BioClinica, Inc.; Paidion Research, Inc.; Instat Consulting, Inc.; ALMAC Clinical...CompletedSkin Diseases | Virus Diseases | DNA Virus Infections | Skin Diseases, Infectious | Warts | Papillomavirus Infections | Skin Diseases, Viral | Tumor Virus Infections | Common Wart | Verruca Vulgaris | Warts Hand | VerrucaUnited States